Prevalence and characteristics of PIK3CA mutation in mismatch repair-deficient colorectal cancer
Weihua Li, Tian Qiu, Lin Dong, Fanshuang Zhang, Lei Guo, Jianming Ying · Journal of Cancer · 2020
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2020
Abstract
Background: Chromosomal instability (CIN) and microsatellite instability (MSI) account for the major causes of colorectal cancer (CRC).As an important component of the CIN pathway, PIK3CA mutation is a negative prognostic factor in CRC.However, the relationship between PIK3CA mutation and mismatch repair (MMR) status has not been well clarified.Methods: MMR status was determined by immunohistochemical assay.KRAS, NRAS, BRAF, PIK3CA and TP53 mutations were comparatively analyzed in 424 MMR-proficient (pMMR) and 104 MMR-deficient (dMMR) CRC tumors using next-generation sequencing (NGS).Results: PIK3CA mutation was more commonly mutated in dMMR tumors.PIK3CA mutation less commonly coexisted with KRAS/NRAS/BRAF and TP53 mutations, but more likely coexisted with HER2 and PTCH1 mutations in dMMR tumors compared with pMMR tumors.In tumors with concurrent RAS/BRAF and PIK3CA mutations, PIK3CA and RAS/BRAF mutant allele frequencies (MAFs) were highly concordant in dMMR tumors, whereas PIK3CA MAFs were significantly lower than the corresponding RAS/BRAF MAFs in pMMR tumors, implying that PIK3CA mutation may occur in the early stage of dMMR CRC.
Conclusions:The molecular pathogenesis is different between dMMR and pMMR tumors with PIK3CA mutation in CRC.PIK3CA mutation may act as a clonally dominant truncal mutation in dMMR CRC.Thus, combination of PIK3CA mutation and MMR status might determine a specific group of CRC to select treatment or elevate prognosis.
Open the resolved locator · 10.7150/jca.37437
Metadata licence: OpenAlex metadata (CC0)